SCHEMBL22952935

SCHEMBL22952935

Oc1c(Cl)cc2c(c1O)CC(c1ccncc1)C1CCNCC21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 5/20 0.54
DRD2 P14416 3/20 0.54
ADRA2A P08913 2/20 0.54
DRD5 P21918 2/20 0.54
DRD3 P35462 2/20 0.54
ADRA2B P18089 1/20 0.54
ADRA2C P18825 1/20 0.54
HTR2C P28335 4/20 0.33
CYP19A1 P11511 1/20 0.32
ROCK2 O75116 1/20 0.32
HTR3A P46098 1/20 0.31
KCNH2 Q12809 2/20 0.30
REN P00797 1/20 0.30
CYP2D6 P10635 3/20 0.30
SLC6A2 P23975 2/20 0.30
SLC6A4 P31645 2/20 0.30
SLC6A3 Q01959 2/20 0.30
KDM4E B2RXH2 3/20 0.30
RECQL P46063 3/20 0.30
CYP3A4 P08684 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22952999 0.84 ADRA2A (0.45) DRD1DRD2ADRA2ADRD5DRD3
SCHEMBL22952930 0.82 ADRA2A (0.78) DRD1DRD2ADRA2ADRD5DRD3
SCHEMBL22953001 0.78 ADRA2A (0.37) DRD1DRD2ADRA2ADRD5DRD3
SCHEMBL22952996 0.75 DRD1 (0.65) DRD1DRD2ADRA2ADRD5DRD3
SCHEMBL22952938 0.74 ADRA2A (0.39) DRD1DRD2ADRA2ADRD5DRD3
SCHEMBL22952932 0.72 ADRA2A (0.68) DRD1DRD2ADRA2ADRD5DRD3
SCHEMBL22953004 0.72 ADRA2A (0.45) DRD1DRD2ADRA2ADRD5DRD3
SCHEMBL22952994 0.70 ADRA2A (0.65) DRD1DRD2ADRA2ADRD5DRD3
SCHEMBL22952992 0.70 DRD1 (0.65) DRD1DRD2ADRA2ADRD5DRD3
SCHEMBL22953002 0.70 ADRA2A (0.65) DRD1DRD2ADRA2ADRD5DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021021922-A1 COMPOUNDS AND METHODS FOR TREATING FIBROTIC PATHOLOGIES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2021-02-04 WO disclosed